Medable Stock

www.medable.comHealthcareFounded: 2012Funding to Date: $530.96MM

Medable is a cloud-based platform providing effective therapies to patients. The platform streamlines design, recruitment, retention and data quality for decentralized trials, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution.

Register for Details

For more details on financing and valuation for Medable, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Medable.

Register Today

Other companies like Medable in the Healthcare sector

Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.33B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$67.5MM
Sector
Last Round Est. Valuation
$1.19B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$8.18B

News

Medable, a Palo Alto CA-based provider of a cloud platform for patient-centered clinical research, raised $304M in Series D funding at $2.1 Billion valuation
Medable Inc., the leading cloud platform for patient-centered clinical research, today announced $304 million in Series D funding to accelerate global adoption of digital and decentralized clinical trials, enabling ubiquitous access to the latest treatments for every body and every biology. The funding round was co-led by new investors Blackstone Growth and Tiger Global and existing investor GSR Ventures. The round also includes follow-on investment from existing investors Sapphire Ventures and WTI.